Lovatinib mesylate

Product situation:

English product name: Lenvatinib mesylate

English alias: 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Aminophenoxy)-7-Methoxy-6-Quinolinecarboxamide

Molecular formula: C22H23CIN4O7S

Structural type

Molecular weight: 522.95862

CAS No.: 857890-39-2

Character: light yellow to white powder

Quality standard: enterprise standard

Package: 25kg/barrel

Content: 99.7%

EINECS：812-398-0

Melting point:>220 ° C

Purpose: Anti tumor API, scientific research, export

The lovatinib mesylate (CAS: 857890-39-2) produced by our company is one of our main products, with purity higher than 99%, and is now sold in large quantities. Welcome to inquire.

Our main lovatinib APIs and intermediates:

Levatinib mesylate: 857890-39-2

4-Chloro-7-methoxyquinoline-6-carboxylic acid methyl ester: 205448-66-4

4-Chloro-7-methoxyquinoline-6-formamide: 417721-36-9

Methyl 4 - ((2,2-dimethyl-4,6-dioxo-1,3-dioxo-5-yl) methylamino) - 2-methoxybenzoate: 205448-64-2

7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylic acid methyl ester: 205448-65-3

4-Amino-3-chlorophenol hydrochloride: 52671-64-4

4-Amino-3-chlorophenol: 17609-80-2

2-Chloro-4-hydroxybenzoate: 796848-80-1

N - (2-chloro-4-hydroxyphenyl) - N '- cyclopropyl - urea: 796848-79-8

We are a quasi-listed enterprise specializing in the production of raw materials and pharmaceutical intermediates, integrating scientific research, production and sales. The company is committed to the synthesis of drugs in many fields, especially in the production and sales of "platinum series", tini, pemetrexed disodium, racecadotril, terbinafine and other products, and is in a domestic advantageous position. More than 80% of the company's products are exported, and have won praise from customers at home and abroad.

The company covers an area of 200000 square meters and has two production bases in Jibei Economic Development Zone in Jinan and Yucheng in Dezhou. The company now has a number of independent intellectual property rights, In 2011, it was recognized as "intellectual property pilot enterprise "The Enterprise Technology Research and Development Center has been recognized as the municipal engineering technology center. With its complete quality assurance system and strong scientific research and innovation strength, the company has launched synthetic drugs with high technical content every year. At present, more than 80 kinds of raw materials and pharmaceutical intermediates have been put into production stably, and many products have passed the GMP and CEP certification. We are willing to provide you with efficient services with higher requirements and competitive prices.

Company advantages:

1. The production plant has sufficient and stable supply of goods, diversified packaging and customized

2. Whole industrial chain production, price advantage, strict quality control

3. Complete qualification and safety assurance

4. Quasi-listed company with strong strength and strong scientific research force

5. Continuous launch of new products to keep up with the market